CG Oncology Exceeds Even The 'Most Bullish Conversations;' Shares Break Out
CG Oncology said Monday its experimental bladder cancer treatment cut the risk of recurrence by 68%. The biotech stock broke out.
The post CG Oncology Exceeds Even The 'Most Bullish Conversations;' Shares Break Out appeared first on Investor's Business Daily .